Seiko Shigeta

This inventor holds 11 USPTO granted patents, plus 2 CIPO patents. Top assignees: Fumakilla Limited, Hiroshima University, Amateraspharma Inc.. Active years: 1994-2013.

USPTO Granted Patents = 11

% Patents Active = 72.7

CIPO Patents = 2

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 95(Granted Patents)

Location History:

Hiroshima-ken, JP (1998 - 2012)
Hiroshima, JP (1994 - 2013)

Company Filing History:

Sharp Kabushiki Kaisha Corporation

where one patent can have more than one assignee

Years Active: 1994-2013

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8420326 - Method of evaluating performance of activation gas deactivating antigenic substance and apparatus for generating processed antigenic substance used as evaluation sample of the evaluating method (2013-04-16),

2. 8263004 - Method and apparatus for deactivating antigenic substance through positive and negative ions functions (2012-09-11),

3. 8187602 - Anti-histone H1 monoclonal antibody and hybridoma for the production thereof (2012-05-29),

4. 7964554 - Polypeptide that binds anti-histone H1 antibody (2011-06-21),

5. 6958229 - Method for producing highly unsaturated fatty acids and lipid containing same (2005-10-25),

6. 6054125 - Purified mite allergen (2000-04-25),

7. 5773010 - Low molecular weight allergen obtained from Dermatophagoides farinae (1998-06-30),

8. 5747047 - Purified mite allergen (1998-05-05),

9. 5496554 - Purified mite allergen (1996-03-05),

10. 5405758 - DNA encoding the recombinant 40 kDA Dermatophagoides farinae allergen (1995-04-11),

11. 5314991 - Recombinant 40 KDa Dermatophagoides farinae allergen (1994-05-24),

Title: Seiko Shigeta: Innovator in Antigenic Substance Deactivation

Introduction

Seiko Shigeta is a prominent inventor based in Hiroshima, Japan. He has made significant contributions to the field of antigenic substance deactivation, holding a total of 11 patents. His innovative methods and apparatuses have advanced the understanding and evaluation of activation gases in relation to antigenic substances.

Latest Patents

Shigeta's latest patents include a method of evaluating the performance of activation gas deactivating antigenic substances. This method involves causing the antigenic substance and the activation gas to react, resulting in a processed antigenic substance. The evaluation method allows for accurate and easy assessment of the performance of the activation gas. Another notable patent is a method and apparatus for deactivating antigenic substances through the use of positive and negative ions. This invention utilizes an atmosphere with high concentrations of both positive and negative ions to effectively deactivate the antigenic substances.

Career Highlights

Throughout his career, Seiko Shigeta has worked with notable organizations such as Fumakilla Limited and Hiroshima University. His work in these institutions has allowed him to collaborate with other experts in the field and further his research on antigenic substances.

Collaborations

Some of his coworkers include Kazuhisa Ono and Satoru Oka, who have contributed to his research endeavors. Their collaboration has enriched the development of innovative solutions in the field of antigenic substance deactivation.

Conclusion

Seiko Shigeta's contributions to the field of antigenic substance deactivation through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in evaluating and deactivating antigenic substances.